Cannabis Bioscience International Holdings (CBIH) Common Equity (2022 - 2026)
Cannabis Bioscience International Holdings' Common Equity history spans 5 years, with the latest figure at -$1.5 million for Q1 2026.
- On a quarterly basis, Common Equity fell 19.71% to -$1.5 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.5 million, a 19.71% decrease, with the full-year FY2025 number at -$1.2 million, down 7.84% from a year prior.
- Common Equity hit -$1.5 million in Q1 2026 for Cannabis Bioscience International Holdings, down from -$1.4 million in the prior quarter.
- Over the last five years, Common Equity for CBIH hit a ceiling of -$405301.0 in Q4 2022 and a floor of -$1.5 million in Q1 2026.
- Historically, Common Equity has averaged -$982067.9 across 5 years, with a median of -$1.1 million in 2024.
- Biggest five-year swings in Common Equity: plummeted 107.72% in 2023 and later dropped 7.84% in 2025.
- Tracing CBIH's Common Equity over 5 years: stood at -$405301.0 in 2022, then plummeted by 107.72% to -$841886.0 in 2023, then plummeted by 34.8% to -$1.1 million in 2024, then decreased by 20.12% to -$1.4 million in 2025, then decreased by 7.62% to -$1.5 million in 2026.
- Business Quant data shows Common Equity for CBIH at -$1.5 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.2 million in Q3 2025.